Jennifer Petrie

BSc (Hons) University of Glasgow

School of Medicine and Population Health

Trial Manager

j.petrie@sheffield.ac.uk
+44 114 222 0676

+44 114 273 0870 (Fax)

Barber House

Full contact details

Jennifer Petrie
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ

Profile

I joined the University of Sheffield in June 2016 having previously worked as a Trial Manager at the MRC Clinical Trials Unit at UCL where I was involved in the management of a number of large phase III IMP trials.

Within CTRU, I work as a Trial Manager on the OPTION-DM and StarMS Trials. OPTION-DM is a phase III trial looking at different treatment pathways for painful diabetic neuropathy. OPTION-DM is closed to recruitment and results are expected by the end of 2021. StarMS is a phase III trial looking at autologous stem cell transplantation for relapsing remitting MS. StarMS is currently in set up with recruitment due to commence in 2021.

Research interests

Controlled clinical trials
Clinical trials methodology

Current projects:

OPTION-DM (Optimal Pathway for TreatIng neuropathic paiN in Diabetes Mellitus)
STAR MS: Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Petrie J, Loban A, Turton E, Derebecka J, North S, Herbert E & Hind D (2024) “Reality is frequently inaccurate” A case study examining the whens and whys of post-live database changes in a UK clinical trials unit *Douglas Adams. Contemporary Clinical Trials, 142. View this article in WRRO
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O , Coles AJ et al (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ Open, 14(2). View this article in WRRO
Marincowitz C, Stone T, Bath P, Campbell R, Turner JK, Hasan M, Pilbery R, Thomas BD, Sutton L, Bell F , Biggs K et al (2024) Accuracy of telephone triage for predicting adverse outcomes in suspected COVID-19: an observational cohort study. BMJ Quality and Safety, 33(6). View this article in WRRO
Brittain G, Coles AJ, Giovannoni G, Muraro PA, Palace J, Petrie J, Roldan E, Scolding NJ, Snowden JA & Sharrack B (2023) Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?. Practical Neurology, 23(2), 139-145. View this article in WRRO
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technology Assessment, 26(39). View this article in WRRO
Hasan M, Bath PA, Marincowitz C, Sutton L, Pilbery R, Hopfgartner F, Mazumdar S, Campbell R, Stone T, Thomas B , Bell F et al (2022) Pre-hospital prediction of adverse outcomes in patients with suspected COVID-19 : development, application and comparison of machine learning and deep learning methods. Computers in Biology and Medicine, 151, Part A. View this article in WRRO
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet, 400(10353), 680-690. View this article in WRRO
Sharrack B, Petrie J, Coles A & Snowden JA (2022) Is stem cell transplantation safe and effective in multiple sclerosis?. British Medical Journal, 377.
Marincowitz C, Stone T, Hasan M, Campbell R, Bath PA, Turner J, Pilbery R, Thomas BD, Sutton L, Bell F , Biggs K et al (2022) Accuracy of emergency medical service telephone triage of need for an ambulance response in suspected COVID-19 : an observational cohort study. BMJ Open, 12(5). View this article in WRRO
Marincowitz C, Sutton L, Stone T, Pilbery R, Campbell R, Thomas B, Turner J, Bath PA, Bell F, Biggs K , Hasan M et al (2022) Prognostic accuracy of triage tools for adults with suspected COVID-19 in a prehospital setting : an observational cohort study. Emergency Medicine Journal, 39, 317-324. View this article in WRRO
Selvarajah D, Petrie J, White D, Julious S, Bortolami O, Cooper C, Bradburn M, Loban A, Bowler H, Swaby L , Sutherland K et al (2018) Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. Trials, 19. View this article in WRRO
Bielicki J, Sharland M, Lyttle M, Hartshorn S & Petrie J (2016) EMERGENCY DEPARTMENT RE-ATTENDANCES AND TREATMENT MODIFICATIONS IN YOUNG CHILDREN WITH UNCOMPLICATED COMMUNITY-ACQUIRED PNEUMONIA: A PERUKI STUDY. Emergency Medicine Journal, 33(12), 933.3-934.

Preprints

Marincowitz C, Stone T, Hasan M, Campbell R, Bath PA, Turner J, Pilbery R, Thomas B, Sutton L, Bell F , Biggs K et al (2021) Accuracy of emergency medical service telephone triage of need for an ambulance response in suspected COVID-19: An observational cohort study, Cold Spring Harbor Laboratory.
Marincowitz C, Stone T, Bath P, Campbell R, Turner J, Hussein M, Pilbery R, Thomas B, Sutton L, Bell F , Biggs K et al (2021) Accuracy of telephone triage for predicting adverse outcome in suspected COVID-19: An observational cohort study, Cold Spring Harbor Laboratory.
Hasan M, Bath P, Marincowitz C, Sutton L, Pilbery R, Hopfgartner F, Mazumdar S, Campbell R, Stone T, Benjamin T , Bell F et al () Pre-hospital prediction of adverse outcomes in patients with suspected COVID-19 : development, application and comparison of machine learning and deep learning methods. View this article in WRRO